Tagawa, S. T., Milowsky, M. I., Morris, M., Vallabhajosula, S., Christos, P., Akhtar, N. H., . . . Nanus, D. M. (2013). Phase II study of lutetium-177 labeled anti-prostate-specific membrane antigen (PSMA) monoclonal antibody J591 for metastatic castration-resistant prostate cancer.
Παραπομπή Chicago StyleTagawa, Scott T., et al. Phase II Study of Lutetium-177 Labeled Anti-prostate-specific Membrane Antigen (PSMA) Monoclonal Antibody J591 for Metastatic Castration-resistant Prostate Cancer. 2013.
Παραπομπή MLATagawa, Scott T., et al. Phase II Study of Lutetium-177 Labeled Anti-prostate-specific Membrane Antigen (PSMA) Monoclonal Antibody J591 for Metastatic Castration-resistant Prostate Cancer. 2013.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.